[1]
Y. Houbaida, M. L. Del Giudice, S. Galimberti, and G. Buda, “Guest Editor: Pellegrino Musto HOW FIRST LINE THERAPY IS CHANGING IN TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA PATIENTS”, Mediterr J Hematol Infect Dis, vol. 17, no. 1, p. e2025026, Feb. 2025.